CAMP CAMP4 Therapeutics Corporation

Fundamentals / CIK 0001736730 / USD

CAMP4 Therapeutics Corporation reported $5.32M in revenue and a net loss of $121.1M for the trailing twelve months ended September 30, 2026 (up 138.9% year over year), with a -1001.1% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CAMP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$11.94M$5.97M$0-$75.47MFY 2023 Revenue: $350KFY 2023 Net Income: -$49.29M2023FY 2024 Revenue: $652KFY 2024 Net Income: -$51.79M2024FY 2025 Revenue: $3.50MFY 2025 Net Income: -$80.40M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue $3.50M $652K $350K
Research & Development $38.20M $38.82M $40.62M
Total Operating Expenses $56.05M $53.74M $52.23M
Operating Income -$52.55M -$53.09M -$51.88M
EBITDA -$50.92M -$51.39M -$50.20M
Interest Income $2.17M $1.33M $2.81M
Income Tax Expense $0 $0 $0
Net Income -$80.40M -$51.79M -$49.29M
Basic EPS -$2.65 -$11.04 -$124.80
Diluted EPS -$2.65 -$11.04 -$124.80
Basic Shares Outstanding 30.4M 4.7M 395.0K
Diluted Shares Outstanding 30.4M 4.7M 395.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $1.90M $1.78M $1.29M $348K $795K $1.50M $858K --
Research & Development $11.43M $10.82M $10.16M $7.86M $9.85M $10.34M $10.15M $10.00M
Total Operating Expenses $15.93M $15.16M $14.37M $13.12M $14.45M $14.53M $13.96M $14.69M
Operating Income -$14.03M -$13.38M -$13.07M -$12.78M -$13.65M -$13.03M -$13.10M -$14.03M
EBITDA -$13.51M -$12.87M -$12.55M -$12.40M -$13.23M -$12.60M -$12.68M -$13.62M
Interest Income $984K $807K $910K $710K $423K $453K $588K $610K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$28.96M -$33.53M -$18.33M -$40.28M -$15.10M -$12.59M -$12.43M -$13.28M
Basic EPS -$0.37 -$0.58 -$0.32 -- -$0.55 -$0.62 -$0.62 --
Diluted EPS -$0.37 -$0.58 -$0.32 -- -$0.55 -$0.62 -$0.62 --
Basic Shares Outstanding 78.9M 57.9M 57.9M -- 27.3M 20.2M 20.2M --
Diluted Shares Outstanding 78.9M 57.9M 57.9M -- 27.3M 20.2M 20.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $109.5M $64.04M $38.38M
Cash & Short-Term Investments $109.5M $64.04M $38.38M
Other Current Assets $342K $211K $245K
Total Current Assets $114.1M $66.38M $40.01M
Property, Plant & Equipment, Net $2.34M $3.86M $4.80M
Other Non-Current Assets $83K $427K --
Total Non-Current Assets $3.71M $11.92M $14.93M
Total Assets $117.8M $78.31M $54.95M
Accounts Payable $182K $1.21M $1.04M
Deferred Revenue (Current) $9.39M $385K $0
Other Current Liabilities $27K $176K --
Total Current Liabilities $15.51M $9.60M $7.81M
Deferred Revenue (Non-Current) $8.11M $0 --
Other Non-Current Liabilities $29K $72K $2.0K
Total Non-Current Liabilities $54.59M $5.57M $8.72M
Total Liabilities $70.10M $15.16M $16.53M
Total Debt (incl. Leases) $1.97M $8.65M $11.69M
Common Stock $6.0K $2.0K $1.0K
Retained Earnings -$292.2M -$211.8M -$160.0M
Total Stockholders' Equity $47.70M $63.14M -$123.7M
Total Equity $47.70M $63.14M -$123.7M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $124.5M $86.40M $99.21M $109.5M $75.25M $39.05M $49.32M $64.04M
Cash & Short-Term Investments $124.5M $86.40M $99.21M $109.5M $75.25M $39.05M $49.32M $64.04M
Other Current Assets $240K $331K $388K $342K $204K $333K $362K $211K
Total Current Assets $127.5M $90.03M $102.2M $114.1M $77.71M $41.09M $51.67M $66.38M
Property, Plant & Equipment, Net $1.68M $1.85M $1.93M $2.34M $2.90M $3.41M $3.60M $3.86M
Other Non-Current Assets $61K $68K $76K $83K -- -- -- $427K
Total Non-Current Assets $6.48M $3.40M $3.26M $3.71M $8.69M $10.19M $11.10M $11.92M
Total Assets $134.0M $93.43M $105.5M $117.8M $86.39M $51.27M $62.77M $78.31M
Accounts Payable $760K $1.09M $863K $182K $585K $1.20M $1.40M $1.21M
Deferred Revenue (Current) $10.50M $13.01M $11.07M $9.39M $0 $0 $0 $385K
Other Current Liabilities -- -- -- $27K -- -- -- $176K
Total Current Liabilities $19.86M $19.14M $16.62M $15.51M $7.90M $7.33M $6.44M $9.60M
Deferred Revenue (Non-Current) $2.18M $1.50M $5.21M $8.11M -- -- -- $0
Other Non-Current Liabilities $49K $31K $30K $29K -- $2.0K $2.0K $72K
Total Non-Current Liabilities $7.05M $74.98M $57.93M $54.59M $19.82M $3.95M $4.76M $5.57M
Total Liabilities $26.92M $94.12M $74.56M $70.10M $27.73M $11.29M $11.20M $15.16M
Total Debt (incl. Leases) $6.45M $2.37M $2.12M $1.97M $6.35M $7.12M $7.87M $8.65M
Common Stock $7.0K $6.0K $6.0K $6.0K $5.0K $2.0K $2.0K $2.0K
Retained Earnings -$373.0M -$344.0M -$310.5M -$292.2M -$251.9M -$236.8M -$224.2M -$211.8M
Total Stockholders' Equity $107.1M -$693K $30.90M $47.70M $58.67M $39.99M $51.57M $63.14M
Total Equity $107.1M -$693K $30.90M $47.70M $58.67M $39.99M $51.57M $63.14M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$80.40M -$51.79M -$49.29M
Depreciation & Amortization $1.64M $1.70M $1.68M
Stock-Based Compensation $4.00M $4.03M $2.91M
Change in Payables -$1.03M $168K -$1.11M
Operating Cash Flow -$29.55M -$45.56M -$44.16M
Capital Expenditure -$279K -$441K -$678K
Free Cash Flow -$29.83M -$46.00M -$44.83M
Investing Cash Flow -$243K -$441K -$678K
Common Stock Issued $57.52M $76.35M $0
Financing Cash Flow $75.89M $71.66M $301K
Net Change in Cash $46.09M $25.66M -$44.53M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$28.96M -$33.53M -$18.33M -$40.28M -$15.10M -$12.59M -$12.43M -$13.28M
Depreciation & Amortization $523K $515K $520K $372K $416K $430K $421K $418K
Stock-Based Compensation $2.02M $1.93M $1.47M $1.15M $984K $1.00M $861K $797K
Change in Payables -$346K $319K $592K -$467K -$546K -$190K $175K -$856K
Operating Cash Flow -$8.16M -$12.69M -$10.98M $6.29M -$11.22M -$10.34M -$14.29M -$11.29M
Capital Expenditure -$740K -$129K $0 $0 $0 $0 -$279K -$263K
Free Cash Flow -$8.90M -$12.81M -$10.98M $6.29M -$11.22M -$10.34M -$14.56M -$11.55M
Investing Cash Flow -$740K -$129K $0 $0 $36K $0 -$279K -$263K
Common Stock Issued -- -- -- $28.55M $28.96M $0 $0 $76.32M
Financing Cash Flow $47.03M $4.0K $57K $28.59M $47.38M $72K -$151K $73.06M
Net Change in Cash $38.12M -$12.81M -$10.92M $34.88M $36.20M -$10.27M -$14.72M $61.51M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Operating Margin -1502.4% -8142.3% -14822.6%
Net Profit Margin -2298.5% -7943.4% -14083.1%
Return on Equity (ROE) -168.5% -82.0% --
Return on Assets (ROA) -68.2% -66.1% -89.7%
Current Ratio 7.35x 6.92x 5.13x
Quick Ratio 7.06x 6.67x 4.92x
Debt to Equity 0.04x 0.14x --
Revenue Growth (YoY) +436.5% +86.3% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -1001.1% -1254.2% -1335.2% -1502.4% -- -- -- --
Net Profit Margin -2276.3% -2543.7% -2193.7% -2298.5% -- -- -- --
Return on Equity (ROE) -113.1% -- -279.3% -168.5% -91.0% -129.5% -100.4% -82.0%
Return on Assets (ROA) -90.4% -114.8% -81.8% -68.2% -61.8% -101.0% -82.5% -66.1%
Current Ratio 6.42x 4.70x 6.15x 7.35x 9.83x 5.60x 8.02x 6.92x
Quick Ratio 6.27x 4.51x 5.97x 7.06x 9.52x 5.32x 7.66x 6.67x
Debt to Equity 0.06x -- 0.07x 0.04x 0.11x 0.18x 0.15x 0.14x
Revenue Growth (YoY) +138.9% +18.8% +50.8% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001736730) · from March 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:42 UTC · Open in terminal